1. Real‐world data on the effectiveness, safety and drug survival of dupilumab: an analysis from the TREATgermany registry. (1st December 2022) Authors: Stölzl, Dora; Sander, Nicole; Heratizadeh, Annice; Haufe, Eva; Harder, Inken; Abraham, Susanne; Heinrich, Luise; Kleinheinz, Andreas; Wollenberg, Andreas; Weisshaar, Elke; Schäkel, Knut; Ertner, Konstantin; Wiemers, Franca; Wildberger, Julia; Worm, Margitta; von Kiedrowski, Ralph; Effendy, Isaak;... Journal: British journal of dermatology Issue: Volume 187:Number 6(2022) Page Start: 1022 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Real‐world data on the effectiveness, safety and drug survival of dupilumab: an analysis from the TREATgermany registry. (6th September 2022) Authors: Stölzl, Dora; Sander, Nicole; Heratizadeh, Annice; Haufe, Eva; Harder, Inken; Abraham, Susanne; Heinrich, Luise; Kleinheinz, Andreas; Wollenberg, Andreas; Weisshaar, Elke; Schäkel, Knut; Ertner, Konstantin; Wiemers, Franca; Wildberger, Julia; Worm, Margitta; von Kiedrowski, Ralph; Effendy, Isaak;... Journal: British journal of dermatology Issue: Volume 187:Number 6(2022) Page Start: 1022 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Real‐world effectiveness of guselkumab in patients with psoriasis: Health‐related quality of life and efficacy data from the noninterventional, prospective, German multicenter PERSIST trial. Issue 12 (12th September 2021) Authors: Gerdes, Sascha; Bräu, Beate; Hoffmann, Matthias; Korge, Bernhard; Mortazawi, Dariusch; Wiemers, Franca; Wegner, Sven; Personke, Yvonne; Gomez, Mario; Sticherling, Michael Journal: Journal of dermatology Issue: Volume 48:Issue 12(2021) Page Start: 1854 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗